Mindray Medical International Limited (NYSE:MR)

CAPS Rating: 3 out of 5

The Company is a developer, manufacturer and marketer of medical devices in China.

Recs

1
Player Avatar 37weeks (56.42) Submitted: 8/11/2010 9:30:25 PM : Underperform Start Price: $25.67 MR Score: +16.77

China has dampened The second Qurter earnings for MR and no change is in sight.

Featured Broker Partners


Advertisement